$25.1 B

ZBH Mkt cap, 15-Oct-2018
Zimmer Biomet EBIT (Q2, 2018)601 M

Zimmer Biomet Revenue

Zimmer Biomet revenue was $7.68 b in FY, 2016 which is a 28.1% year over year increase from the previous period.

Embed Graph

Zimmer Biomet Revenue Breakdown

Embed Graph

Zimmer Biomet revenue breakdown by business segment: 8.6% from Spine & CMF, 5.6% from Dental, 21.4% from S.E.T, 24.3% from Hips, 35.8% from Knees and 4.3% from Other

Zimmer Biomet Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

4.6b4.7b6.0b7.7b

Revenue growth, %

1%28%28%

Cost of goods sold

1.3b1.2b1.8b2.4b

Gross profit

3.3b3.4b4.2b5.3b

Gross profit Margin, %

72%73%70%69%

EBIT

1.0b1.0b467.3m825.9m

EBIT margin, %

22%22%8%11%

Interest expense

70.1m63.1m286.6m357.9m

Interest income

15.6m11.9m9.4m2.9m

Pre tax profit

981.1m943.9m153.2m399.6m

Income tax expense

221.9m224.9m7.0m95.0m

Net Income

759.2m719.0m146.2m304.6m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.1b1.2b1.2b1.1b1.1b1.2b176.2m1.9b1.9b1.8b2.0b2.0b1.8b

Cost of goods sold

328.8m305.4m333.2m298.3m278.7m290.5m552.1m635.2m640.1m479.3m512.9m527.7m

Gross profit

745.5m856.1m849.7m807.7m855.7m877.1m(375.9m)1.3b1.3b1.4b1.5b1.4b

Gross profit Margin, %

69%74%72%73%75%75%(213%)67%67%74%74%73%

R&D expense

49.4m47.5m48.1m46.1m48.4m51.4m83.3m85.7m88.6m95.6m91.1m90.1m

General and administrative expense

438.0m464.3m455.8m443.5m425.0m445.1m692.3m716.9m732.0m727.7m760.8m748.0m

Operating expense total

487.4m511.8m503.9m489.6m473.4m496.5m775.6m802.6m820.6m823.3m851.9m838.1m

EBIT

211.7m298.4m259.3m251.2m274.9m(129.5m)116.0m245.5m201.6m195.5m350.4m282.3m213.4m

EBIT margin, %

20%26%22%23%24%(11%)66%13%10%11%18%14%12%

Interest expense

17.1m15.0m15.8m16.3m23.1m82.7m90.8m88.2m88.1m91.5m82.9m82.3m82.3m

Interest income

3.8m2.5m2.9m3.0m2.6m2.5m2.3m1.3m800.0k600.0k500.0k300.0k600.0k

Pre tax profit

198.4m285.9m236.4m227.4m231.8m(213.7m)31.8m154.8m110.5m103.5m265.2m196.4m127.2m

Income tax expense

44.3m64.8m60.3m62.1m55.0m(55.5m)9.6m49.0m142.2m(54.4m)(34.1m)12.3m

Net Income

154.1m221.1m176.1m165.3m176.8m(158.2m)22.2m105.8m(31.7m)157.9m299.3m184.1m98.8m

Zimmer Biomet Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

1.1b1.1b1.5b634.1m

Accounts Receivable

936.6m912.1m1.4b1.6b

Prepaid Expenses

107.1m193.7m538.4m465.7m

Inventories

1.1b1.2b2.3b2.0b

Current Assets

4.2b4.3b5.9b4.7b

PP&E

1.2b1.3b2.1b2.0b

Goodwill

2.6b2.5b9.9b10.6b

Total Assets

9.6b9.6b27.2b26.7b

Accounts Payable

146.3m167.1m284.8m364.5m

Short-term debt

575.6m1.2b

Current Liabilities

1.0b1.0b1.6b2.4b

Long-term debt

1.7b1.4b11.6b10.7b

Total Debt

1.7b1.4b11.6b11.2b1.2b

Total Liabilities

3.3b3.1b17.3b17.0b14.2b

Common Stock

2.6m2.7m3.0m3.1m

Additional Paid-in Capital

4.0b4.3b8.2b8.4b

Retained Earnings

7.7b8.3b8.3b8.5b

Total Equity

6.3b6.5b9.9b9.7b

EPS

4.44.20.81.5

Debt to Equity Ratio

0.3 x0.2 x1.2 x1.2 x

Debt to Assets Ratio

0.2 x0.1 x0.4 x0.4 x

Financial Leverage

1.5 x1.5 x2.8 x2.8 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

917.4m882.7m968.7m967.3m8.8b1.4b1.5b996.8m976.3m475.3m1.0b450.0m480.8m

Accounts Receivable

869.8m1.5b1.4b1.6b1.6b1.6b1.6b1.4b

Prepaid Expenses

246.8m551.7m475.8m420.7m518.9m535.8m463.3m527.2m

Inventories

1.1b1.1b1.1b1.2b1.2b2.4b2.4b2.1b2.0b2.1b2.0b2.0b2.1b

Current Assets

3.8b4.0b4.2b4.3b11.9b6.8b6.4b5.1b5.1b4.7b5.1b4.4b4.4b

PP&E

1.2b1.2b1.3b1.3b1.3b2.0b2.0b2.0b2.0b2.1b2.1b2.1b

Goodwill

2.6b2.6b2.6b2.5b2.4b7.7b7.7b10.1b10.0b10.8b10.7b10.9b10.9b

Total Assets

9.4b9.4b9.6b9.7b17.2b27.2b26.7b26.3b26.0b27.0b27.0b26.5b26.4b

Accounts Payable

146.6m155.3m171.8m149.1m174.9m268.2m223.6m252.6m243.8m266.3m335.9m360.2m327.1m

Short-term debt

300.0k225.0m500.0k575.8m975.0m1.3b1.2b1.6b100.0m

Current Liabilities

804.2m918.7m952.9m1.1b908.7m2.2b1.8b1.5b2.1b2.3b2.7b3.0b3.0b

Long-term debt

1.7b1.7b1.7b1.4b9.1b11.7b11.7b11.1b10.5b11.0b10.5b9.4b9.2b

Total Debt

1.7b1.7b1.7b1.4b9.1b11.8b11.9b11.1b10.5b11.6b11.5b10.7b10.4b1.6b100.0m

Total Liabilities

3.2b3.1b3.2b3.1b10.6b17.1b16.7b16.6b16.4b17.3b17.1b16.2b16.0b

Common Stock

2.7m3.0m3.0m3.0m3.0m3.0m3.1m3.0m

Additional Paid-in Capital

3.8b4.1b4.2b4.3b4.4b8.1b8.2b8.2b8.3b8.3b8.4b8.5b8.5b

Retained Earnings

7.5b7.9b8.0b8.2b8.4b8.2b8.3b8.4b8.3b8.4b8.6b8.8b8.8b

Total Equity

6.1b6.2b6.5b6.5b6.6b10.1b10.0b966.1m9.5b9.7b9.9b1.0b10.5b

EPS

1.0(0.9)0.10.5(0.2)0.81.50.9

Debt to Equity Ratio

1.4 x1.2 x1.2 x11.5 x1.1 x1.2 x1.2 x10.4 x1 x

Debt to Assets Ratio

0.5 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x

Financial Leverage

1.5 x1.5 x1.5 x1.5 x2.6 x2.7 x2.7 x27.2 x2.7 x2.8 x2.7 x25.7 x2.5 x

Zimmer Biomet Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

759.2m719.0m146.2m304.6m

Depreciation and Amortization

358.5m375.8m712.4m1.0b

Accounts Receivable

(74.3m)(40.4m)(56.1m)(137.8m)

Inventories

(128.4m)(154.1m)(205.4m)76.4m

Accounts Payable

38.3m120.1m(263.1m)28.7m

Cash From Operating Activities

963.1m1.1b816.7m1.6b

Purchases of PP&E

(100.0m)(144.9m)(167.7m)(184.7m)

Cash From Investing Activities

(282.5m)(469.4m)(7.6b)(1.7b)

Cash From Financing Activities

(467.3m)(562.4m)7.1b(743.2m)

Net Change in Cash

196.3m2.7m376.0m(825.2m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018

Net Income

154.1m221.1m176.1m165.3m176.8m18.6m19.5m105.8m77.0m234.9m299.3m483.4m98.8m

Depreciation and Amortization

89.0m188.6m428.1m246.9m499.2m787.3m267.6m531.7m

Accounts Receivable

6.6m(59.3m)29.4m(83.4m)(120.8m)(80.3m)26.8m228.8m

Inventories

(62.2m)(149.9m)(196.5m)38.3m60.2m44.2m(11.5m)(68.8m)2.1b

Accounts Payable

(149.5m)95.8m(251.5m)(120.7m)(141.9m)(76.0m)(137.0m)(203.7m)327.1m

Cash From Operating Activities

91.5m278.3m429.6m265.2m652.4m1.0b275.4m715.9m

Purchases of PP&E

(34.4m)(64.8m)(118.6m)(27.6m)(73.7m)(130.1m)(431.0m)(73.8m)

Cash From Investing Activities

67.9m(7.7b)(7.7b)95.8m(170.4m)(1.5b)(133.1m)(262.1m)

Cash From Financing Activities

7.6b7.8b7.7b(825.3m)(953.3m)(434.1m)256.1m(656.9m)(729.0m)

Net Change in Cash

7.6b341.3m383.6m(462.5m)(483.0m)(984.0m)405.4m(184.1m)
Report incorrect company information

Zimmer Biomet Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017

Countries

100 100 100 100

Patents and Patent Applications

4.50 k7 k8 k8 k
Report incorrect company information